Efficacy News and Research

RSS
Lauric-acid-filled nano-scale bombs for treating acne

Lauric-acid-filled nano-scale bombs for treating acne

Early, accurate detection of superficial bladder cancer with Olympus PDD

Early, accurate detection of superficial bladder cancer with Olympus PDD

Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine

Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine

AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting

AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting

Ibuprofen demonstrates efficacy over acetaminophen for treatment of pain and fever

Ibuprofen demonstrates efficacy over acetaminophen for treatment of pain and fever

Interim results from Pharmasset's phase 2a combination study of PSI-7977 with Pegasys and Copegus for HCV

Interim results from Pharmasset's phase 2a combination study of PSI-7977 with Pegasys and Copegus for HCV

Phase Forward's European Users Conference to be held in Budapest, Hungary

Phase Forward's European Users Conference to be held in Budapest, Hungary

Patients with RLS using rotigotine achieve sustained improvements

Patients with RLS using rotigotine achieve sustained improvements

Potential new drug for treatment of MS to be presented at AAN Annual Meeting

Potential new drug for treatment of MS to be presented at AAN Annual Meeting

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

Efficacy data from Phase III STAR trial of Zenvia presented at AAN Annual Meeting

Opexa Therapeutics presents key efficacy data on Tovaxin

Opexa Therapeutics presents key efficacy data on Tovaxin

Synosia Therapeutics presents data from phase 2a clinical study of SYN-115 in PD

Synosia Therapeutics presents data from phase 2a clinical study of SYN-115 in PD

Phase II clinical study examining CTT's Calmare pain therapy medical device completed

Phase II clinical study examining CTT's Calmare pain therapy medical device completed

New UCLA study compares safety and efficacy of angioplasty to bypass surgery

New UCLA study compares safety and efficacy of angioplasty to bypass surgery

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

Phase IIa clinical trial results of Serdaxin for treatment of MDD

Phase IIa clinical trial results of Serdaxin for treatment of MDD

ErbB3 program development candidate selection triggers $5M milestone payment to AVEO Pharmaceuticals

ErbB3 program development candidate selection triggers $5M milestone payment to AVEO Pharmaceuticals

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

52% migraine sufferers found relief from headache with Aspirin: review

52% migraine sufferers found relief from headache with Aspirin: review

FDA approves J&JPRD's PANCREAZE NDA

FDA approves J&JPRD's PANCREAZE NDA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.